Compliance Rate
Compliance Rate
36.36%
Compliant submissions
8
Incompliant submissions
14
Total trials
22
My Organizations' Clinical Trials
Showing 1150 of 1641 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/31/08
End: 06/30/13
Due: 06/30/14
Phase: N/A
Priority: Normal
Start: 02/14/24
End: 08/31/25
Due: 08/31/26
Phase: N/A
Priority: Normal
Start: 05/03/21
End: 05/09/25
Due: 05/09/26
Phase: N/A
Priority: Normal
Start: 10/04/21
End: 06/30/26
Due: 06/30/27
Pembrolizumab and Lenvatinib in Patients With Brain Metastases From Melanoma or Renal Cell Carcinoma
Phase: N/A
Priority: Normal
Start: 02/09/22
End: 05/28/25
Due: 05/28/26
Phase: N/A
Priority: Normal
Start: 06/30/25
End: 09/30/26
Due: 09/30/27
Phase: N/A
Priority: Normal
Start: 02/28/11
End: 07/31/13
Due: 07/31/14
Phase: N/A
Priority: Normal
Start: 09/30/16
End: 01/31/20
Due: 01/31/21
Phase: N/A
Priority: Normal
Start: 04/21/25
End: 06/30/29
Due: 06/30/30
Phase: N/A
Priority: Normal
Start: 10/31/12
End: 06/30/14
Due: 06/30/15
Phase: N/A
Priority: Normal
Start: 08/31/15
End: 04/05/17
Due: 04/05/18
Phase: N/A
Priority: Normal
Start: 04/03/24
End: 10/31/27
Due: 10/31/28
Phase: N/A
Priority: Normal
Start: 08/27/13
End: 06/30/21
Due: 06/30/22
Phase: N/A
Priority: Normal
Start: 05/01/22
End: 12/31/23
Due: 12/31/24
Phase: N/A
Priority: Normal
Start: 05/06/19
End: 02/23/23
Due: 02/23/24
Phase: N/A
Priority: Normal
Start: 07/31/12
End: 07/31/13
Due: 07/31/14
Phase: N/A
Priority: Normal
Start: 07/20/20
End: 03/01/22
Due: 03/01/23
Phase: N/A
Priority: Normal
Start: 12/31/13
End: 06/30/16
Due: 06/30/17
Phase: N/A
Priority: Normal
Start: 08/31/13
End: 11/30/13
Due: 11/30/14
Phase: N/A
Priority: Normal
Start: 12/31/08
End: 05/08/14
Due: 05/08/15
Phase: N/A
Priority: Normal
Start: 03/31/09
End: 07/31/14
Due: 07/31/15
Phase: N/A
Priority: Normal
Start: 07/31/20
End: 07/31/30
Due: 07/31/31
Phase: N/A
Priority: Normal
Start: 05/31/15
End: 11/30/15
Due: 11/30/16
Phase: N/A
Priority: Normal
Start: 02/28/11
End: 08/31/12
Due: 08/31/13
Phase: N/A
Priority: Normal
Start: 08/31/12
End: 05/13/20
Due: 05/13/21